EQH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
EQH is not a strong buy right now for a beginner long-term investor, but it is a reasonable hold/watchlist candidate. The stock has supportive merger news and positive analyst sentiment, yet the chart is still technically mixed-to-bearish and there is no Intellectia buy signal today. Since the user is impatient and wants a direct answer, the best call is to wait rather than buy immediately.
Current price is 42.52, basically flat versus the previous close, with the broader market also positive. The technical picture is not bullish: MACD histogram is negative at -0.152, RSI_6 is neutral at 57.723, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5. That setup suggests the trend is not yet confirmed upward. Key levels are pivot 42.194, resistance at 44.182 and 45.411, support at 40.206 and 38.977. The stock has some short-term upside potential, but the current trend does not support an aggressive buy.
The biggest positive catalyst is the Corebridge merger. News indicates a leadership team has been announced, governance appears organized, and the combined company is expected to manage over $1.5 trillion in assets and serve more than 12 million customers. Analysts have also been raising price targets, and hedge funds have been buying aggressively, with buying up 173.14% over the last quarter. These are meaningful long-term positives.
The chart is still not confirming a clean uptrend, and the bearish moving average structure limits confidence in an immediate entry. There are no insider buying signals, no recent congress trading data, and no Intellectia AI Stock Picker or SwingMax signal today. The options market shows a put-heavy open interest profile, which tempers sentiment. The merger also still depends on approvals and is expected to close only by the end of 2026, so some upside is still event-dependent.
No usable latest-quarter financial snapshot was provided because the financial snapshot section returned an error. Based on the analyst notes, Q1 was described positively, with strong retirement margins, favorable mortality, and a Q1 beat. That implies improving operational performance in the latest reported quarter, but exact revenue, earnings, and growth figures are unavailable here. Latest quarter season appears to be Q1 2026.
Wall Street sentiment is clearly positive overall. Recent ratings are mostly Overweight/Outperform, with several firms lifting targets: Wells Fargo to 57, Mizuho to 61, Keefe Bruyette to 60, Barclays to 51, Raymond James upgraded to Strong Buy with 58, Evercore to 63, and UBS to 58. One JPMorgan note trimmed its target slightly to 57, and Mizuho earlier cut to 58, but the dominant trend is upward target revisions and bullish ratings. Pros: merger synergies, better distribution scale, in-house asset management, and favorable Q1 results. Cons: some valuation/target caution, life insurance setup remains challenging, and the stock still lacks a confirmed technical breakout.
